American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on August 24, 2026

Aug. 24, 2026

Inside the Multibillion-Dollar Race to Build the AI Economy's Physical Backbone

Indeterminate GlobeNewswire

Aug. 24, 2026

EVA LIVE EXPANDS INTO GLOBAL GAMING MARKET PROJECTED TO EXCEED $200 BILLION THROUGH MAJORITY OWNERSHIP OF INTERNATIONAL GAMING ALLIANCE

Indeterminate GlobeNewswire

Aug. 24, 2026

Alkeus Pharmaceuticals Announces Japan Ministry of Health, Labour and Welfare (MHLW) Has Granted Orphan Drug Designation to Gildeuretinol for Stargardt Disease

Indeterminate GlobeNewswire

Aug. 24, 2026

Bond CEO to Host Investor Webinar Shedding Light on Recent Announcements and Developments

Indeterminate GlobeNewswire

Aug. 24, 2026

New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026

Indeterminate GlobeNewswire

Aug. 24, 2026

TSI Delivers Total Visibility and Control with Facility Management System with Web Client 2.0

Indeterminate GlobeNewswire

Aug. 24, 2026

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

Indeterminate GlobeNewswire

Aug. 24, 2026

Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

Indeterminate GlobeNewswire

Aug. 24, 2026

GOxCALL Turns Any Screen Into a Queue Counter

Indeterminate EIN Presswire

Aug. 24, 2026

TravelDistro Opens QR-Issued Attraction Tickets for Türkiye's Landmarks via a Single API

Indeterminate EIN Presswire

Aug. 24, 2026

Evolution Metals & Technologies Corp. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes

Indeterminate GlobeNewswire

Aug. 24, 2026

Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions

Indeterminate GlobeNewswire

Aug. 24, 2026

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Indeterminate GlobeNewswire

Aug. 24, 2026

ADARx Pharmaceuticals Receives FDA Fast Track Designation for Onvuzosiran for the Treatment of HAE

Indeterminate GlobeNewswire

Aug. 24, 2026

AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer

Indeterminate GlobeNewswire

Aug. 24, 2026

Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma

Indeterminate GlobeNewswire

Aug. 24, 2026

Merlin Designated a New Zealand Part 146 Aircraft Design Organization, Advancing Its Path to Commercial Operations

Indeterminate GlobeNewswire

Aug. 24, 2026

Datacentrex Secures Colocation Capacity and Set to Expand Mining Fleet by More Than 500 Additional ElphaPex DG2 Miners

Indeterminate GlobeNewswire

Aug. 24, 2026

Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan

Indeterminate GlobeNewswire

Aug. 24, 2026

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

Indeterminate GlobeNewswire